Emily Valentino

Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology

Nitya Raj, Emily Valentino, Marinela Capanu et al. · Pancreas · 2016 · 109 citations · Full text

Medicine, Oncology, Chemotherapy +15

A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies

James J. Harding, Imane El Dika, Ellen Hollywood et al. · Cancer Chemotherapy and Pharmacology · 2018 · 46 citations

Medicine, Oncology, Pharmacology +15

Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma

Ghassan K. Abou‐Alfa, Robert J. Mayer, Alan P. Venook et al. · The Oncologist · 2020 · 45 citations · Full text

Medicine, Oncology, Pharmacology +14

Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers

Maeve A. Lowery, Mikaela Bradley, Joanne F. Chou et al. · Clinical Cancer Research · 2018 · 35 citations · Full text

Medicine, Oncology, Pharmacology +13

A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC).

James J. Harding, Joseph P. Erinjeri, Benjamin Tan et al. · Journal of Clinical Oncology · 2018 · 14 citations

Life Sciences, Immunology, Pharmacology +17